These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 31359796

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Inhalation toxicity of Cyclosarin (GF) vapor in rats as a function of exposure concentration and duration: potency comparison to sarin (GB).
    Anthony JS, Haley M, Manthei J, Way R, Burnett D, Gaviola B, Sommerville D, Crosier R, Mioduszewski R, Thomson S, Crouse C, Matson K.
    Inhal Toxicol; 2004 Feb; 16(2):103-11. PubMed ID: 15204783
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Single whole-body exposure to sarin vapor in rats: long-term neuronal and behavioral deficits.
    Grauer E, Chapman S, Rabinovitz I, Raveh L, Weissman BA, Kadar T, Allon N.
    Toxicol Appl Pharmacol; 2008 Mar 01; 227(2):265-74. PubMed ID: 18164360
    [Abstract] [Full Text] [Related]

  • 6. Protection and inflammatory markers following exposure of guinea pigs to sarin vapour: comparative efficacy of three oximes.
    Levy A, Chapman S, Cohen G, Raveh L, Rabinovitz I, Manistersky E, Kapon Y, Allon N, Gilat E.
    J Appl Toxicol; 2004 Mar 01; 24(6):501-4. PubMed ID: 15558827
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interaction of exposure concentration and duration in determining acute toxic effects of sarin vapor in rats.
    Mioduszewski R, Manthei J, Way R, Burnett D, Gaviola B, Muse W, Thomson S, Sommerville D, Crosier R.
    Toxicol Sci; 2002 Apr 01; 66(2):176-84. PubMed ID: 11896284
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A critical role of acute bronchoconstriction in the mortality associated with high-dose sarin inhalation: effects of epinephrine and oxygen therapies.
    Gundavarapu S, Zhuang J, Barrett EG, Xu F, Russell RG, Sopori ML.
    Toxicol Appl Pharmacol; 2014 Jan 15; 274(2):200-8. PubMed ID: 24269878
    [Abstract] [Full Text] [Related]

  • 11. The dose-response effects of repeated subacute sarin exposure on guinea pigs.
    Hulet SW, McDonough JH, Shih TM.
    Pharmacol Biochem Behav; 2002 Jul 15; 72(4):835-45. PubMed ID: 12062573
    [Abstract] [Full Text] [Related]

  • 12. Long- and short-term changes in the neuroimmune-endocrine parameters following inhalation exposures of F344 rats to low-dose sarin.
    Peña-Philippides JC, Razani-Boroujerdi S, Singh SP, Langley RJ, Mishra NC, Henderson RF, Sopori ML.
    Toxicol Sci; 2007 May 15; 97(1):181-8. PubMed ID: 17301067
    [Abstract] [Full Text] [Related]

  • 13. The effects of repeated low-dose sarin exposure.
    Shih TM, Hulet SW, McDonough JH.
    Toxicol Appl Pharmacol; 2006 Sep 01; 215(2):119-34. PubMed ID: 16556454
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Post-exposure treatment with nasal atropine methyl bromide protects against microinstillation inhalation exposure to sarin in guinea pigs.
    Che MM, Conti M, Chanda S, Boylan M, Sabnekar P, Rezk P, Amari E, Sciuto AM, Gordon RK, Doctor BP, Nambiar MP.
    Toxicol Appl Pharmacol; 2009 Sep 15; 239(3):251-7. PubMed ID: 19523969
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of sarin and cyclosarin toxicity by subcutaneous, intravenous and inhalation exposure in Gottingen minipigs.
    Hulet SW, Sommerville DR, Miller DB, Scotto JA, Muse WT, Burnett DC.
    Inhal Toxicol; 2014 Feb 15; 26(3):175-84. PubMed ID: 24517840
    [Abstract] [Full Text] [Related]

  • 20. Propagation of damage in the rat brain following sarin exposure: Differential progression of early processes.
    Lazar S, Egoz I, Brandeis R, Chapman S, Bloch-Shilderman E, Grauer E.
    Toxicol Appl Pharmacol; 2016 Nov 01; 310():87-97. PubMed ID: 27639427
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.